Tower Research Capital (TRC)’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04K | Sell |
2,785
-653
| -19% | -$712 | ﹤0.01% | 4562 |
|
|
2025
Q1 | $4.3K | Buy |
3,438
+993
| +41% | +$1.24K | ﹤0.01% | 4278 |
|
|
2024
Q4 | $3.84K | Sell |
2,445
-415
| -15% | -$652 | ﹤0.01% | 4575 |
|
|
2024
Q3 | $5.46K | Sell |
2,860
-4,524
| -61% | -$8.64K | ﹤0.01% | 4269 |
|
|
2024
Q2 | $14.5K | Buy |
7,384
+4,155
| +129% | +$8.14K | ﹤0.01% | 3947 |
|
|
2024
Q1 | $7.65K | Buy |
3,229
+1,354
| +72% | +$3.21K | ﹤0.01% | 4174 |
|
|
2023
Q4 | $4.05K | Buy |
1,875
+657
| +54% | +$1.42K | ﹤0.01% | 5001 |
|
|
2023
Q3 | $2.56K | Buy |
+1,218
| New | +$2.56K | ﹤0.01% | 5135 |
|
|
2023
Q2 | – | Sell |
-505
| Closed | -$1K | – | 6265 |
|
|
2023
Q1 | $1K | Buy |
505
+298
| +144% | +$590 | ﹤0.01% | 5594 |
|
|
2022
Q4 | $1K | Buy |
207
+110
| +113% | +$531 | ﹤0.01% | 5649 |
|
|
2022
Q3 | $0 | Sell |
97
-1,064
| -92% | – | ﹤0.01% | 6391 |
|
|
2022
Q2 | $2K | Buy |
+1,161
| New | +$2K | ﹤0.01% | 5584 |
|
|
2022
Q1 | – | Sell |
-650
| Closed | -$2K | – | 6451 |
|
|
2021
Q4 | $2K | Sell |
650
-6,420
| -91% | -$19.8K | ﹤0.01% | 5651 |
|
|
2021
Q3 | $22K | Buy |
+7,070
| New | +$22K | ﹤0.01% | 3638 |
|